share_log

全球首个艾滋病毒疫苗研发取得重大进展 将使用mRNA平台

MRNA platform will be used to make significant progress in the development of the world's first HIV vaccine.

格隆滙 ·  Apr 9, 2021 20:24
Researchers are about to try to develop an HIV vaccine using the latest mRNA (messenger ribonucleic acid) technology platform. Phase I clinical data show that the vaccine has shown the effectiveness of anti-HIV. By the end of this year, new trials of HIV vaccines will be conducted based on Moderna's mRNA platform.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment